NEW YORK, April 6 (GenomeWeb News) - Genaissance Pharmaceuticals said today that it has signed agreements with the University of Rochester and the Mayo Clinic for access to clinical research samples, associated data, and intellectual property around certain disease-associated mutations that it will use in developing genetic tests for cardiac disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.